u/Avish_Golakiya · 3h ago7 prior · awaiting results
“Held since August at $4.84 average, currently $3.99”
10 penny biotechs I'm watching and slowly adding for September 2026, and the one I got wrong in August.
Azenosertib shows ~35% ORR in Cyclin E1-positive platinum-resistant ovarian cancer and will present full DENALI overall survival data at ESMO Oct 23-27. The author held it at $4.84 in August and retains position despite 18% drawdown.
Now $3.9928m ago